linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 AGM  
Glaxosmithkline Pharmaceuticals Ltd.
 
Source DateAGM Date Details
13-May-2025 27-Jun-2025 Inter alia, approved:- 1. Dividend The Board has recommend...
04-Jun-2024 28-Jun-2024
17-May-2023 26-Jul-2023
16-May-2022 26-Jul-2022 Inter alia, approved: 1. Dividend The Board has recommend...
28-Jun-2021 27-Jul-2021
18-May-2020 27-Jul-2020
20-May-2019 22-Jul-2019 A.G.M. & ...
24-May-2018 24-Jul-2018 A.G.M. & ...
19-May-2017 25-Jul-2017 Pursuant to Regulation 30 and Schedule III (A) (12) of the Lis...
25-May-2016 28-Jul-2016 Rs.50.0000 per share(500%)Dividend ...
18-May-2015 31-Jul-2015 Rs.62.5000 per share(625%)Dividend ...
18-Feb-2014 17-Apr-2014
10-Apr-2013 16-Apr-2013 GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that the ...
10-Apr-2012 10-Apr-2012
29-Mar-2011 29-Mar-2011
25-Mar-2010 25-Mar-2010
02-Apr-2009 02-Apr-2009
21-Apr-2008 21-Apr-2008
30-Mar-2007 30-Mar-2007
12-Apr-2006 12-Apr-2006
Page 1 of 2
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.